Entering text into the input field will update the search result below

Apyx files for FDA expanded approval of Renuvion APR Handpiece

Feb. 01, 2023 8:44 AM ETApyx Medical Corporation (APYX) StockBy: Ravikash Bakolia, SA News Editor

Food And Drug Administration Headquarters In Maryland

Sarah Silbiger

  • Apyx Medical (NASDAQ:APYX) said it submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for expanded use of Renuvion APR Handpiece.
  • The company is seeking to include a specific indication for the use of Renuvion

Recommended For You

More Trending News

About APYX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
APYX--
Apyx Medical Corporation